News

  • Boost for firm aiming to close women’s heart health care gap

    Virtual care firm Systole Health has raised US$2m to advance it mission to address  "underdiagnosed and undertreated" cases of women's heart conditions. Its platform enables women at risk of heart disease to meet virtually with doctors and health coaches to receive personalised coaching and medical care; and access to a "supportive community". While each session [...]

  • Webinar to explore impact of AI ‘Super Agents’ on healthcare

    AI Super Agents: What They Are and Their Potential Global Health Impact Artificial General Intelligence (AGI) represents a significant advancement in AI, with the potential to create systems that can learn, reason, and solve problems across various fields — potentially in ways that exceed human capabilities. Opinions differ on the timeline for AGI development. Sam [...]

  • Therapeutic HPV vaccine could eliminate precancerous cervical lesions

    A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase 2 clinical trial. In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical cancer [...]

  • PTSD and anxiety may affect reproductive health of women firefighters – study

    Post-traumatic stress disorder and anxiety are associated with lower levels of anti-Müllerian hormone, a marker of ovarian reserve, among women firefighters, new research has found. The ovarian reserve is the number of healthy eggs in a woman’s ovaries that could potentially be fertilised. It is a measure of a woman’s fertility and ability to have [...]

  • SiS Solve pitch event, New York: Over $50,000 in awards for women’s health innovators

    SiS Solve, a global leader in driving innovation within women’s health, has announced the launch of SiS Solve New York 2025, a pitch event offering over $50,000 worth of prizes to empower founders addressing unmet needs in women’s health. SiS: Women’s Health delivers real, actionable insights to build investable and scalable businesses in women’s health. [...]

  • Alarming decline in women’s cancer testing worldwide, report reveals

    There has been a "shocking" decline in testing for cancer in women across the globe, a new report has revealed. Only 10 per cent of women surveyed worldwide said they were tested for any type of cancer in the past year, down two percentage points from the first two years of the Hologic Global Women’s [...]

  • Chain IVF clinics increase access to treatment and enhance outcomes

    Corporate chain ownership of fertility clinics not only increases access to treatment but also enhances patient outcomes, a new study shows. The study shows that chain-owned clinics perform 27.2 per cent more IVF cycles and achieve a 13.6 per cent improvement in success rates. They also adopt standardised practices that reduce risky multiple births while [...]

  • Telephone therapy reduces fatigue for metastatic breast cancer survivors

    Telephone-delivered acceptance and commitment therapy (ACT) is beneficial for reducing fatigue’s interference with functioning and improves the quality of life for survivors of metastatic breast cancer, a new study has revealed. Fatigue is a significant challenge for people with metastatic breast cancer, affecting up to 63 per cent of patients and severely impacting daily functioning. [...]

  • Europe’s first tissue bank for women launches in Liverpool

    Europe's first private, women's health tissue bank has been launched by Liverpool-based laboratory and medical education provider BioGrad, backed by a £25m investment. The new tissue bank will work to investigate treatments and cures for women's health conditions such as menopause, endometriosis, cancers, and polycystic ovarian syndrome (PCOS), according to reports. The bank aims to [...]

  • Zero Candida lists on Frankfurt Stock Exchange

    FemTech medical device company Zero Candida Technologies has listed on the Frankfurt Stock Exchange (FSE) under the trading symbol "9L2". The listing expands Zero Candida's global presence, now cross-listed on both the TSX Venture Exchange and the FSE. The company is developing an AI-driven, tampon-like device that uses a therapeutic light source with a selected [...]